Not Signed In - Ranbaxy Receives USFDA Approval for Zidovudine Tablets
Thu, 14 Jul 2005 03:00 AM EST
... Ranbaxy Laboratories Limited (RLL) announced today that it has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets 300 mg... click link for more info. ...
Related Topics
- Lamivudine and Zidovudine
- Carbinoxamine and Pseudoephedrine Tablets
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Abacavir, Zidovudine and Lamivudine
- Cyanocobalamin Tablets
- Zidovudine
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Thiabendazole Tablets
- Neostigmine Tablets
- Haloperidol Tablets
- Lamivudine
- Carbetapentane, Phenylephrine, and Pyrilamine
- Ergoloid Mesylates Sublingual Tablets
- Nystatin Tablets
- Desmopressin Tablets
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Tarceva
- Gatifloxacin tablets
email this page
print this page
bookmark this page
feedback on this page
